Adjuvant Chemoradiotherapy vs Radiotherapy Alone for Patients With Intermediate-Risk Cervical Cancer
The results of this cohort study suggest that adding chemotherapy to radiotherapy was not associated with improved overall survival for patients with intermediate-risk cervical cancer.
Authors
- Alexander Melamed (ORCID: https://orcid.org/0000-0002-0654-0863)
- Abigail Zamorano (ORCID: https://orcid.org/0000-0002-5641-5649)
- Chi‐Fang Wu (ORCID: https://orcid.org/0000-0001-7086-6609)
- Alexa Kanbergs (ORCID: https://orcid.org/0000-0001-9040-441X)
- Núria Agustí (ORCID: https://orcid.org/0000-0002-1165-0661)
- Roni Nitecki Wilke (ORCID: https://orcid.org/0000-0002-6176-9441)
- J. Alejandro Rauh‐Hain
- René Pareja (ORCID: https://orcid.org/0000-0003-0093-0438)
- David Viveros‐Carreño (ORCID: https://orcid.org/0000-0001-9395-0627)
- Karla Barajas (ORCID: https://orcid.org/0009-0009-4456-3765)
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Massachusetts General Hospital (US)
- Instituto Nacional de Cancerología (CO)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- JAMA Oncology
- Published
- 2025-03-13
- DOI
- https://doi.org/10.1001/jamaoncol.2025.0146
- Citations
- 11
- Primary Topic
- Endometrial and Cervical Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 22.63